Vicplas International posts $2.4m net loss in FY2025

The group’s loss per share was $0.0046.

Vicplas International reported a net loss of $2.4m in FY2025, mainly due to weaker earnings from its pipes and fittings segment and higher finance costs.

However, the group’s revenue increased by 13.1% year on year (YoY) to $115.8m from $102.4m in FY2024.

Revenue for the medical devices segment was up 22.3% to $77.2m, due to an increase in orders as customers adjusted post-pandemic inventory holdings.

The pipes and fittings segment recorded a slight decrease in revenue of 1.7% to $38.6m as the group tightened credit risk controls and adjusted prices in line with lower raw material costs.

Adjusted EBITDA increased by 16.2% to $8.5m.

The group’s loss per share was $0.0046.

Follow the link for more news on

Financial Statements

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia